{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/QCRH/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T16:20:16.359Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9741,"canonical_name":"QCR HOLDINGS INC","cik":"0000906465","uei":null,"lei":null,"duns":null,"ticker":"QCRH"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":14},"count":14,"timeline":[{"ts":"2026-08-24","kind":"sec.filing","form_type":"8-K","title":"8-K — QCR HOLDINGS INC — 2026-08-24","url_slug":"/sec/cik-0000906465/8-k/0001171843-26-005713","accession_number":"0001171843-26-005713","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"10-Q","title":"10-Q — QCR HOLDINGS INC — 2026-08-07","url_slug":"/sec/cik-0000906465/10-q/0001104659-26-092545","accession_number":"0001104659-26-092545","importance":45},{"ts":"2026-08-01","kind":"sec.insider.m","reporter":"Winter Reba K","title":"EVP, COO","shares":302,"price_per_share":70.01,"usd_value":21143,"security_title":"Common Stock","importance":15.02114302},{"ts":"2026-08-01","kind":"sec.insider.m","reporter":"Winter Reba K","title":"EVP, COO","shares":310,"price_per_share":58.65,"usd_value":18182,"security_title":"Common Stock","importance":15.0181815},{"ts":"2026-08-01","kind":"sec.insider.m","reporter":"Winter Reba K","title":"EVP, COO","shares":350,"price_per_share":51.81,"usd_value":18134,"security_title":"Common Stock","importance":15.0181335},{"ts":"2026-08-01","kind":"sec.insider.m","reporter":"Winter Reba K","title":"EVP, COO","shares":246,"price_per_share":73.49,"usd_value":18079,"security_title":"Common Stock","importance":15.01807854},{"ts":"2026-07-22","kind":"sec.filing","form_type":"8-K","title":"8-K — QCR HOLDINGS INC — 2026-07-22","url_slug":"/sec/cik-0000906465/8-k/0001104659-26-085795","accession_number":"0001104659-26-085795","importance":35},{"ts":"2026-07-22","kind":"sec.filing","form_type":"8-K","title":"8-K — QCR HOLDINGS INC — 2026-07-22","url_slug":"/sec/cik-0000906465/8-k/0001104659-26-085796","accession_number":"0001104659-26-085796","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"11-K","title":"11-K — QCR HOLDINGS INC — 2026-06-29","url_slug":"/sec/cik-0000906465/11-k/0001171843-26-004340","accession_number":"0001171843-26-004340","importance":30},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Ekizian Laura L","title":"President & CEO, QCBT","shares":750,"price_per_share":94.96,"usd_value":71220,"security_title":"Common Stock","importance":35.07122},{"ts":"2026-06-09","kind":"sec.insider.m","reporter":"Ekizian Laura L","title":"President & CEO, QCBT","shares":750,"price_per_share":45,"usd_value":33750,"security_title":"Common Stock","importance":15.03375},{"ts":"2026-06-02","kind":"sec.insider.p","reporter":"Reasner Amy L","title":null,"shares":60,"price_per_share":90.25,"usd_value":5415,"security_title":"Common Stock","importance":50.005415},{"ts":"2026-06-02","kind":"sec.insider.m","reporter":"Klein James D.","title":"President, CRBT","shares":94,"price_per_share":66.52,"usd_value":6253,"security_title":"Common Stock","importance":15.00625288},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Lee Nicole A","title":"EVP, Chief HR Officer","shares":234,"price_per_share":38.81,"usd_value":9082,"security_title":"Common Stock","importance":15.00908154}]}